DE FOUGEROLLES, Antonin,DIENER, John, L.,HICKMAN, Emma,HINKLE, Gregory,MILSTEIN, Stuart,PULICHINO, Anne-Marie,SPRAGUE, Andrew
申请号：
DK11715243
公开号：
DK2561077T3
申请日:
2011.04.20
申请国别(地区):
DK
年份:
2016
代理人:
摘要：
The present disclosure relates to RNAi agents useful in methods of treating Beta-ENaC-related diseases such as cystic fibrosis, pseudohypoaldosteronism type 1 (PHA1), Liddle's syndrome, hypertension, alkalosis, hypokalemia, and obesity-associated hypertension, using a therapeutically effective amount of a RNAi agent to Beta-ENaC.
